The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

HRVBgp1  -  genome polyprotein

Human rhinovirus B14

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of HRVBgp1

  • Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein [1].
  • Implications of the picornavirus capsid structure for polyprotein processing [2].
  • Human rhinovirus, the chief cause of the common cold, contains a positive-sense strand of RNA which is translated into a large polyprotein in infected cells [3].
  • In the case of HRVs, these small single-stranded positive-sense RNA viruses translate their genetic information into a polyprotein precursor which is further processed mainly by two viral proteases designated 2A and 3C [4].
 

High impact information on HRVBgp1

  • Most maturation cleavages within the precursor polyprotein are mediated by rhinovirus 3C protease (or its immediate precursor, 3CD), a cysteine protease with a trypsin-like polypeptide fold [5].
  • Nucleotide sequences coding for the complete polyprotein, the RNA polymerase, and VP1 were analyzed separately [6].
  • Compound 1 inhibited HRV 3C-mediated polyprotein processing in infected cells in a concentration-dependent manner, providing direct confirmation that the cell-based antiviral activity is due to inhibition of 3C protease [7].
  • Deletions in the 5' non-coding sequence modulated viral polyprotein synthesis significantly in a reticulocyte lysate system [8].
  • The predicted amino acid sequence of the polyprotein shows close homology (88%) to that of the previously sequenced coxsackievirus B3 and to certain regions of the polyproteins of the polioviruses and human rhinovirus 14 [9].
 

Chemical compound and disease context of HRVBgp1

 

Biological context of HRVBgp1

 

Associations of HRVBgp1 with chemical compounds

  • The enzyme activity of the purified protease was measured by cleavage of a synthetic peptide representing a predicted Gln/Gly viral polyprotein cleavage site [13].
  • Several peptides mimicking the native 3C cleavage site of HRV-14 polyprotein have been synthesized with an N-acylated p-nitroaniline at position P1' and examined as substrates for the purified 3C protease [14].
 

Analytical, diagnostic and therapeutic context of HRVBgp1

  • Western blot analysis of viral proteins from infected cells indicates that this inhibitor works specifically by blocking viral polyprotein maturation, displaying a reduction of detectable 3C protease and an accumulation of the 3CD polypeptide [10].

References

  1. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Matthews, D.A., Smith, W.W., Ferre, R.A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J.E., Janson, C.A., McElroy, H.E., Gribskov, C.L. Cell (1994) [Pubmed]
  2. Implications of the picornavirus capsid structure for polyprotein processing. Arnold, E., Luo, M., Vriend, G., Rossmann, M.G., Palmenberg, A.C., Parks, G.D., Nicklin, M.J., Wimmer, E. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  3. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. Kong, J.S., Venkatraman, S., Furness, K., Nimkar, S., Shepherd, T.A., Wang, Q.M., Aubé, J., Hanzlik, R.P. J. Med. Chem. (1998) [Pubmed]
  4. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. Wang, Q.M. Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques. (2001) [Pubmed]
  5. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Matthews, D.A., Dragovich, P.S., Webber, S.E., Fuhrman, S.A., Patick, A.K., Zalman, L.S., Hendrickson, T.F., Love, R.A., Prins, T.J., Marakovits, J.T., Zhou, R., Tikhe, J., Ford, C.E., Meador, J.W., Ferre, R.A., Brown, E.L., Binford, S.L., Brothers, M.A., DeLisle, D.M., Worland, S.T. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  6. Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Li, F., Browning, G.F., Studdert, M.J., Crabb, B.S. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  7. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Patick, A.K., Brothers, M.A., Maldonado, F., Binford, S., Maldonado, O., Fuhrman, S., Petersen, A., Smith, G.J., Zalman, L.S., Burns-Naas, L.A., Tran, J.Q. Antimicrob. Agents Chemother. (2005) [Pubmed]
  8. Sequences in the 5' non-coding region of human rhinovirus 14 RNA that affect in vitro translation. Alsaadi, S., Hassard, S., Stanway, G. J. Gen. Virol. (1989) [Pubmed]
  9. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. Jenkins, O., Booth, J.D., Minor, P.D., Almond, J.W. J. Gen. Virol. (1987) [Pubmed]
  10. Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing. Murray, M.A., Janc, J.W., Venkatraman, S., Babé, L.M. Antivir. Chem. Chemother. (2001) [Pubmed]
  11. The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Stanway, G., Hughes, P.J., Mountford, R.C., Minor, P.D., Almond, J.W. Nucleic Acids Res. (1984) [Pubmed]
  12. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase. Davis, G.J., Wang, Q.M., Cox, G.A., Johnson, R.B., Wakulchik, M., Dotson, C.A., Villarreal, E.C. Arch. Biochem. Biophys. (1997) [Pubmed]
  13. The expression and purification of human rhinovirus protease 3C. Knott, J.A., Orr, D.C., Montgomery, D.S., Sullivan, C.A., Weston, A. Eur. J. Biochem. (1989) [Pubmed]
  14. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Wang, Q.M., Johnson, R.B., Cox, G.A., Villarreal, E.C., Loncharich, R.J. Anal. Biochem. (1997) [Pubmed]
 
WikiGenes - Universities